CVS Health (NYSE: CVS) reported Q1 EPS of $2.20, $0.10 better than the analyst estimate of $2.10. Revenue for the quarter came in at $85.3 billion versus the consensus estimate of $80.91 billion.

GUIDANCE:

CVS Health sees FY2023 EPS of $8.50-$8.70, from $8.70-$8.90 and versus the consensus of $8.73.

For earnings history and earnings-related data on CVS Health (CVS) click here.